DOI: 10.1021/jm401564r. Discovery of Innovative Therapeutics: Today’s Realities and Tomorrow’s Vision. 2. Pharma’s Challenges and Their Commitment to Innovation

Discovery of Innovative Therapeutics: Today’s Realities and Tomorrow’s Vision. 2. Pharma’s Challenges and Their Commitment to Innovation

10.1021/jm401564r

Crossref journal-article

American Chemical Society (ACS)

Journal of Medicinal Chemistry (316)

Bibliography

Abou-Gharbia, M., & Childers, W. E. (2014). Discovery of Innovative Therapeutics: Todayâs Realities and Tomorrowâs Vision. 2. Pharmaâs Challenges and Their Commitment to Innovation. Journal of Medicinal Chemistry, 57(13), 5525â5553.

Authors 2

Magid Abou-Gharbia (first)
Wayne E. Childers (additional)

References 158 Referenced 42

Arlington, S.From Vision to Decision: Pharma 2020. Technical Report from PricewaterhouseCoopers: 2012; http://www.pwc.com/jp/ja/japan-knowledge/archive/assets/pdf/pharma-2020-vision-to-decision.pdf.
10.1021/jm400330j / J. Med. Chem. by Abou-Gharbia M. (2013)
10.1111/j.1476-5381.2010.01127.x / Br. J. Pharmacol. by Hughes J. (2011)
10.1136/bmj.326.7382.180 / Brit. Med. J. by Grech E. (2003)
10.1007/s00109-011-0729-3 / J. Mol. Med. by Li Y. (2011)
{'key': 'ref6/cit6', 'first-page': '914', 'volume': '4', 'author': 'Harikumar R.', 'year': '2012', 'journal-title': 'Int. J. PharmTech Res.'} / Int. J. PharmTech Res. by Harikumar R. (2012)
{'key': 'ref7/cit7', 'volume-title': 'Topics on Drug Metabolism', 'author': 'Alvarez-Lueje A.', 'year': '2012'} / Topics on Drug Metabolism by Alvarez-Lueje A. (2012)
10.1007/s11481-009-9156-4 / J. Neuroimmune Pharmacol. by Nordstrom A. (2010)
10.1021/cr0782426 / Chem. Rev. by Ametamey S. (2008)
10.2967/jnumed.112.111476 / J. Nucl. Med. by Bailey D. (2013)
10.1007/s00259-010-1390-8 / Eur. J. Nucl. Med. Mol. Imaging by Mariani G. (2010)
Drug Discovery and Development: Understanding the R&D Process; Report from the Pharmaceutical Research and Manufacturers of America:Washington, DC, 2007; http://www.innovation.org/drug_discovery/objects/pdf/RD_Brochure.pdf.
10.1038/nrd2199 / Nat. Rev. Drug Discovery by Overington J. (2006)
10.1038/nrd892 / Nat. Rev. Drug Discovery by Hopkins A. (2002)
10.1038/nrd1156 / Nat. Rev. Drug Discovery by Kubiyni H. (2003)
10.1111/j.1476-5381.2010.01127.x / Br. J. Pharmacol. by Hughes J. (2011)
10.1073/pnas.1204524109 / Proc. Natl. Acad. Sci. U.S.A. by Gregori-Puigjane E. (2012)
10.1126/science.1169920 / Science by Boguski M. (2009)
10.1038/nrd4051 / Nat. Rev. Drug Discovery by Plenge R. M. (2013)
{'key': 'ref20/cit20', 'first-page': '23', 'volume': '1', 'author': 'Chen X.-P.', 'year': '2007', 'journal-title': 'Drug Discovery Ther.'} / Drug Discovery Ther. by Chen X.-P. (2007)
10.1002/cmdc.201100498 / ChemMedChem by Brunschweiger A. (2012)
10.1021/ci800324m / J. Chem. Inf. Model. by Halgren T. (2009)
10.1073/pnas.1300011110 / Proc. Natl. Acad. Sci. U.S.A. by Skolnick J. (2013)
10.1016/j.drudis.2009.09.011 / Drug Discovery Today by Campbell S. (2010)
10.1016/j.cbpa.2006.06.014 / Curr. Opin. Chem. Biol. by Keller T. (2006)
10.1016/j.ddtec.2004.11.007 / Drug Discovery Today by Lipinski C. (2004)
{'key': 'ref27/cit27', 'first-page': '6', 'volume-title': 'New Synthetic Technologies in Medicinal Chemistry', 'author': 'Merritt A.', 'year': '2012'} / New Synthetic Technologies in Medicinal Chemistry by Merritt A. (2012)
{'key': 'ref28/cit28', 'volume-title': 'Drug-Like Properties: Concepts, Structure Design and Methods', 'author': 'Kerns E.', 'year': '2008'} / Drug-Like Properties: Concepts, Structure Design and Methods by Kerns E. (2008)
10.2174/156802611794480927 / Curr. Top. Med. Chem. by Gleeson M. (2011)
10.1038/nrd1470 / Nat. Rev. Drug Discovery by Kola I. (2004)
{'key': 'ref31/cit31', 'volume': '21', 'author': 'Gilbert J.', 'year': '2003', 'journal-title': 'In Vivo Bus. Med. Rep.'} / In Vivo Bus. Med. Rep. by Gilbert J. (2003)
{'key': 'ref32/cit32', 'first-page': '562', 'volume': '75', 'author': 'Kleemann A.', 'year': '2013', 'journal-title': 'Pharm. Ind.'} / Pharm. Ind. by Kleemann A. (2013)
Stone, K.Big pharma’s merger mania.About.com;http://pharma.about.com/od/BigPharma/tp/Big-Pharmas-Merger-Mania.htm.
Deal Search Online Home Page, Irving Levin Associates, Inc.http://www.levinassociates.com/dealsearch/.
10.1038/nrd3514 / Nat. Rev. Drug Discovery by Lamattina J. (2011)
10.1038/nrd2961-c1 / Nat. Rev. Drug Discovery by Firestone R. (2011)
10.1038/nrd2961 / Nat. Rev. Drug Discovery by Munos B. (2009)
Comanor, W.; Scherer, F.Mergers and innovation in the pharmaceutical industry. Harvard Kennedy School Faculty Research Working Paper Series, 2011; https://research.hks.harvard.edu/publications/workingpapers/citation.aspx?PubId=8053&type=FN&PersonId=219. (10.2139/ssrn.2190201)
Amgen Press Release, Aug 25, 2013;http://www.amgen.com/media/media_pr_detail.jsp?releaseID=1849611.
10.1038/nrd3681 / Nat. Rev. Drug Discovery by Scannell J. (2012)
10.1093/oxfordhb/9780199742998.013.0018 / The Oxford Handbook of The Economics of the Biopharmaceutical Industry by Grabowski H. (2012)
10.1057/9781137005908 / Mega Mergers and Acquisitions: Case Studies from Key Industries by Kumar B. (2012)
Tjandrawinata, R.; Simanjuntak, D.The impact of mergers and acquisitions in research-based pharmaceutical companies on productivity.Social Science Research Network:Rochester, NY, 2012; http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1981889. (10.2139/ssrn.1981889)
LaMattina, J.A holiday gift from Merck’s Ken Frazier.Drug Truths, Dec 20, 2011; http://johnlamattina.wordpress.com/2011/12/20/a-holiday-gift-from-mercks-ken-frazier/.
Weaver, C.Merck CEO defends strategy to pursue new drugs, research.Wall Street Journal, Dec 13, 2011; http://online.wsj.com/article/BT-CO-20111213-711338.html.
10.1002/mde.1343 / Managerial and Decision Economics by Danzon P. (2007)
{'key': 'ref47/cit47', 'first-page': '262', 'volume-title': 'Economics of Corporate Governance and Mergers', 'author': 'Grabowski H.', 'year': '2008'} / Economics of Corporate Governance and Mergers by Grabowski H. (2008)
Davis, P. J.Beyond the patent cliff – signs of recovery in biopharma’s new normal.Accenture Life Sciences, 2012; http://www.accenture.com/SiteCollectionDocuments/PDF/Accenture-Life-Sciences-Beyond-The-Patent-Cliff-Signs-Of-Recovery-in-Biopharmas-New-Normal.pdf.
World preview 2018: Embracing the patent cliff.EvaluatePharma, 2012; http://info.evaluatepharma.com/WP2018_ELS_LP.html.
Lipitor sales data.Drugs.com;http://www.drugs.com/stats/lipitor.
10.1126/science.1176116 / Science by Higgins M. (2009)
Paragraph four explained: Why generic drug companies challenge patents.Parry Ashfold, Inc.:Exton, PA, 2012; http://paragraphfour.com/explained/why_challenge.html.
10.1038/nrd3356 / Nat. Rev. Drug Discovery by Harrison C. (2011)
Powers, M.Despite short-term revenue hit, Sanofi manages patent cliff.BioWorld;http://www.bioworld.com/content/despite-short-term-revenue-hit-sanofi-manages-patent-cliff-0.
10.1136/bmj.e7941 / Br. Med. J. by Hitchings A. (2012)
Buente, M.; Danner, S.; Weissbacker, S.; Ramme, C.Pharma emerging markets 2.0. How emerging markets are driving the transformation of the pharmaceutical industry.Booz & Co, 2013; http://www.booz.com/media/file/BoozCo_Pharma-Emerging-Markets-2.0.pdf.
Schumacher, C.CRAMS outsourcing in pharmaceutical and chemical research and manufacturing, part II.StepChange Innovations GmbH, 2012; http://blog.stepchange-innovations.com/2012/08/crams-outsourcing-in-pharmaceutical-and-chemical-research-and-manufacturing-part-ii/#_edn1.
{'key': 'ref58/cit58', 'first-page': '54', 'volume': '14', 'author': 'Getz K.', 'year': '2012', 'journal-title': 'Contract Pharma'} / Contract Pharma by Getz K. (2012)
10.1016/j.respol.2006.01.006 / Res. Policy by Roijakkers N. (2006)
10.1016/j.hitech.2004.03.003 / J. High Technol. Manage. Res. by McCutchen W. W. (2004)
The use of medicines in the United States: Review of 2011.IMS Institute for Healthcare Informatics, April 2012; http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_Report_2011.pdf.
Barry, C.; Arad, R.; Johnston, A.; Parent, A.; Ansell, L.; Arnold, M. (2012) patent litigation study.PricewaterhouseCoopers, Sept 2012;http://www.pwc.com/us/en/forensic-services/publications/2012-patent-litigation-study.jhtml.
10.1056/NEJMp1206573 / N. Engl. J. Med. by Rai A. (2012)
Agreements filed with the Federal Trade Commission under the Medicare Prescription Drug, Improvement and Moderinization Act of 2003: Overview of agreements filed filed in FY 2012; A report by the Bureau of Competition, Federal Trade Commission:Washington, DC, Jan 2013; http://www.ftc.gov/os/2013/01/130117mmareport.pdf.
List of authorized generic drugs.U.S. Food and Drug Administration:Washington , DC;http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ucm126389.htm.
More than eight in ten Americans want the option of choosing authorized generic prescription drugs.Roper Public Affairs & Media, 2005; http://www.prasco.com/wp-content/uploads/2012/03/Roper_Poll.pdf.
Authorized generic drugs: Short-term effects and long-term impact.Federal Trade Commission:Washington, DC, 2011.
10.1007/s12257-012-0095-1 / Biotechnol. Bioprocess Eng. by Ryu J. K. (2012)
Global biopharmaceutical market expected to reach $320 billion by 2020.Global Information, Inc., Oct 4, 2012; http://www.giiresearch.com/press/6805.shtml.
10.1016/S0140-6736(12)60771-5 / Lancet by Stein E. A. (2012)
10.1001/jama.2012.25790 / JAMA by Sullivan D. (2012)
Herd, T.; Sheehy, D. A.; Ural, A.Mergers & acquisitions: A strategy for focused growth in the biopharmaceutical industry during uncertain times.Accenture, 2011; http://www.accenture.com/SiteCollectionDocuments/PDF/Accenture_A_Strategy_for_Focused_Growth.pdf.
{'key': 'ref74/cit74', 'first-page': '2132', 'volume': '4', 'author': 'Kanase S. J.', 'year': '2013', 'journal-title': 'Int. J. Pharm. Sci Res.'} / Int. J. Pharm. Sci Res. by Kanase S. J. (2013)
10.1186/ar3310 / Arthritis Res Ther. by Kay J. (2011)
Patient Protection and Affordable Care Act of 2009, Pub. L. No. 111-148, Title VII, Subtitle A Biologics Price Competition and Innovation Act of 2009, §7001-7003;http://www.gpo.gov/fdsys/pkg/BILLS-111hr3590enr/pdf/BILLS-111hr3590enr.pdf.
{'key': 'ref77/cit77', 'first-page': '451', 'volume-title': 'Annual Reports in Medicinal Chemistry', 'author': 'Notte G. T.', 'year': '2013'} / Annual Reports in Medicinal Chemistry by Notte G. T. (2013)
{'key': 'ref78/cit78', 'first-page': '15', 'author': 'Jarvis L. M.', 'year': '2013', 'journal-title': 'Chem. Eng. News'} / Chem. Eng. News by Jarvis L. M. (2013)
LaMattina, J.When it comes to NDA approvals, is 30 the new 50?Drug Truths, 2012; http://johnlamattina.wordpress.com/2012/01/17/when-it-comes-to-nda-approvals-is-30-the-new-50/.
Armstrong, W.FDA’s approvable problem.Pharmaceutical Executive, Nov 1, 2007; http://www.pharmexec.com/pharmexec/PE+Features/FDAs-Approvable-Problem/ArticleStandard/Article/detail/469652.
FDA revised process for responding to drug applications; Press Release by the U.S. Food and Drug Administration, July 8, 2008; http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116920.htm. Completehttp://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2004-N-0510-nfr.pdf.
10.1136/bmj.e4348 / Br. Med. J. by Light D. (2012)
FDA’s consideration of evidence from certain clinical trials.United States Government Accountability Office, July 2010; http://www.gao.gov/assets/310/308301.pdf.
10.1057/jcb.2008.6 / J. Commer. Biotechnol. by Bode-Greuel K. (2008)
10.1038/clpt.2009.71 / Clin. Pharmacol. Ther. by Poland B. (2009)
Sartori, V.; Steinmann, M.; Evers, M.; Jantzer, P.Value-driven drug development – unlocking the value of your pipeline.McKinsey Quarterly, 2011; http://www.mckinsey.com/Search.aspx?q=sartori&l=Insights%20%26%20Publications.
Dykstra, K.; Hodge, L.; Poland, B.; Carrothers, T. J.Methods for developing differentiated drug products.Pharsight, 2009; http://www.pharsight.com/library/Methods%20for%20Developing%20Differentiated%20Drug%20Products.pdf.
10.1038/nrd3462 / Nature Rev. Drug Discovery by Frye S. (2011)
10.1021/ml400012g / ACS Med. Chem. Lett. by Huryn D. H. (2013)
10.1038/nrd3439-c1 / Nat. Rev. Drug Discovery by Prinz F. (2011)
10.1126/scitranslmed.3000169 / Sci. Transl. Med. by Silber B. M. (2010)
10.1021/jm400132d / J. Med. Chem. by Huryn D. H. (2013)
{'key': 'ref93/cit93', 'first-page': '1', 'volume': '4', 'author': 'Kotz J.', 'year': '2011', 'journal-title': 'SciBX'} / SciBX by Kotz J. (2011)
{'key': 'ref94/cit94', 'first-page': '314', 'volume': '20', 'author': 'Donatella V.', 'year': '2010', 'journal-title': 'Biochemica Medica'} / Biochemica Medica by Donatella V. (2010)
10.1038/nrd1470 / Nat. Rev. Drug Discovery by Kola I. (2004)
10.1111/j.1365-2125.1988.tb03318.x / Br. J. Clin. Pharmacol. by Prentis R. A. (1988)
10.1016/S0169-409X(96)00423-1 / Adv. Drug Delivery Res. by Lapinski P. A. (1997)
10.1038/nrd3367 / Nat. Rev. Drug Discovery by Gleeson M. P. (2011)
10.1016/j.bmcl.2013.08.029 / Bioorg. Med. Chem. Lett. by Shultz M. D. (2013)
10.1007/s10822-012-9631-5 / J. Comput.-Aided Mol. Des. by Kenny P. W. (2013)
10.1021/jm049661n / J. Med. Chem. by Refsgaard H. H. F. (2005)
10.4155/fmc.12.150 / Future Med. Chem. by Peach M. L. (2012)
10.1021/ci2003544 / J. Chem. Inf. Model. by AbdulHameed M. D. (2012)
10.1016/j.taap.2009.08.022 / Toxicol. Appl. Pharmacol. by Valerio L. G. (2009)
10.1021/ci900286s / J Chem. Inf. Model. by Hewitt M. (2009)
{'key': 'ref107/cit107', 'first-page': '53', 'volume-title': 'Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability', 'volume': '40', 'author': 'Davis A. M.', 'year': '2009', 'edition': '2'} / Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability by Davis A. M. (2009)
10.1016/S1359-6446(05)03386-6 / Drug Discovery Today by Abad-Zapatero C. (2005)
10.1016/S1359-6446(04)03069-7 / Drug Discovery Today by Hopkins A. L. (2004)
{'key': 'ref110/cit110', 'volume-title': 'Ligand Efficiency Indices for Drug Discovery: Towards an Atlas-Guided Paradigm', 'author': 'Abad-Zapatero C.', 'year': '2013'} / Ligand Efficiency Indices for Drug Discovery: Towards an Atlas-Guided Paradigm by Abad-Zapatero C. (2013)
10.1038/nrd3552 / Nat. Rev. Drug Discovery by Leeson P. D. (2011)
10.1021/jm100118x / J. Med. Chem. by Perola E. (2010)
10.1021/ci010366a / J. Chem. Inf. Comput. Sci. by Oprea T. I. (2001)
{'key': 'ref114/cit114', 'first-page': '1', 'volume': '2', 'author': 'Shahzad A.', 'year': '2011', 'journal-title': 'Transl. Biomed.'} / Transl. Biomed. by Shahzad A. (2011)
NIH Bench-to-Bedside Program Home Page.http://clinicalcenter.nih.gov/ccc/btb/.
10.1038/nrd1130 / Nat. Rev. Drug Discovery by Frank R. (2003)
10.1067/mcp.2001.113989 / Clin. Pharmacol. Ther. by Biomarkers Definitions Working Group (2001)
10.1097/COH.0b013e32833ed177 / Curr. Opin. HIV AIDS by Strimbu K. (2010)
10.1007/978-1-4419-1132-2_1 / Pharmaceutical Biotechnology: Advances in Experimental Biology and Medicine by Day M. (2009)
10.1016/j.tips.2006.04.004 / Trends Pharmacol. Sci. by Lee C.-M. (2006)
10.1176/ajp.156.2.286 / Am. J. Psychiatry by Kapur S. (1999)
10.1002/cncr.11320 / Cancer by Chawla S. P. (2003)
10.1016/j.biopsych.2005.07.013 / Biol. Psychiatry by Keller M. (2006)
10.1016/S0531-5565(02)00267-X / Exp. Gerentol. by Schirmer M. (2003)
10.1016/S0169-409X(99)00055-1 / Adv. Drug Delivery Rev. by Bhatnager A. (2000)
10.1016/S1359-6446(01)01684-1 / Drug Discovery Today by Aboagye E. O. (2001)
{'key': 'ref127/cit127', 'first-page': 'S19', 'volume': '6', 'author': 'Taneja S. S.', 'year': '2004', 'journal-title': 'Rev. Urol.'} / Rev. Urol. by Taneja S. S. (2004)
10.2214/ajr.183.2.1830519 / Am. J. Roentgenol. by Schettino C. J. (2004)
10.1208/s12248-008-9041-8 / AAPS J by Krishna R. (2008)
10.3390/ijms140611034 / Int. J. Mol. Sci. by Velonas V. M. (2013)
Guidance for Industry: S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. U.S. Food and Drug Administration, Oct 2005; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm074963.pdf.
10.1038/nrd3115 / Nat. Rev. Drug Discovery by Hampel H. (2010)
10.1186/1750-1326-8-20 / Mol. Neurodegener. by Rosen C. (2013)
10.1002/mds.25157 / Mov. Disord. by Ravine B. (2012)
10.1093/brain/awq008 / Brain by Hong Z. (2010)
{'key': 'ref136/cit136', 'first-page': '2825', 'volume': '58', 'author': 'Baselga J.', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. by Baselga J. (1998)
10.1038/nrd3181 / Nat. Rev. Drug Discovery by Schilsky R. L. (2010)
10.1038/nrd3603 / Nat. Rev. Drug Discovery by Chiang A. (2011)
{'key': 'ref139/cit139', 'first-page': '321', 'volume': '17', 'author': 'Sadigh-Eteghad S.', 'year': '2012', 'journal-title': 'Neuroscience'} / Neuroscience by Sadigh-Eteghad S. (2012)
10.1038/sj.mp.4001558 / Mol. Psychiatry by Harrison P. (2005)
10.1002/9783527630035.ch21 / Analogue-Based Drug Discovery II by Abou-Gharbia M. A. (2010)
10.4088/JCP.v64n0301 / J. Clin. Psychiatry by Nelson J. C. (2003)
10.1124/jpet.106.103382 / J. Pharmacol. Exp. Ther. by Deecher D. C. (2006)
10.1021/jm00172a035 / J. Med. Chem. by Yardley J. P. (1990)
10.1097/JCP.0b013e318192e4c1 / J. Clin. Psychopharmacol. by Preskorn S. (2009)
10.1021/jm8012823 / J. Med. Chem. by Abou-Gharbia M. (2009)
10.1351/PAC-CON-11-11-09 / Pure Appl. Chem. by Abou-Gharbia M. (2012)
{'key': 'ref148/cit148', 'first-page': '316', 'volume-title': 'Accounts in Drug Discovery', 'author': 'Graziani E. I.', 'year': '2011'} / Accounts in Drug Discovery by Graziani E. I. (2011)
10.1046/j.1523-1755.2001.00460.x / Kidney Int. by Saunders R. N. (2001)
10.1038/nrd2062 / Nat. Rev. Drug Discovery by Faiver S. (2006)
{'key': 'ref151/cit151', 'first-page': '3749S', 'volume': '7', 'author': 'Skotnicki J. S.', 'year': '2001', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. by Skotnicki J. S. (2001)
10.1038/nrd2382 / Nat. Rev. Drug Discovery by Rini B. (2007)
10.1126/science.273.5272.239 / Science by Choi J. (1996)
10.1038/ja.2006.26 / J. Antibiot. by Summers M. Y. (2006)
10.1073/pnas.0710424105 / Proc. Natl. Acad. Sci. U.S.A. by Ruan B. (2008)
10.1586/erv.09.68 / Expert Rev. Vaccines by Dinleyici E. C. (2009)
10.1345/aph.1Q347 / Ann. Pharmacother. by Sucher A. J. (2011)
10.1111/j.1749-6632.2012.06673.x / Ann. N.Y. Acad. Sci. by Gruber W. C. (2012)
Brant, A.20 top selling vaccines – H1, 2012.FierceVaccines, Sept 25, 2012; http://www.fiercevaccines.com/special-report/20-top-selling-vaccines/2012-09-25.
{'key': 'ref160/cit160', 'first-page': '12', 'volume': '91', 'author': 'Mullin R.', 'year': '2013', 'journal-title': 'Chem. Eng. News'} / Chem. Eng. News by Mullin R. (2013)

Dates

Type	When
Created	11 years, 7 months ago (Jan. 15, 2014, 10:57 a.m.)
Deposited	2 years, 4 months ago (April 5, 2023, 8:53 p.m.)
Indexed	2 months, 1 week ago (June 25, 2025, 1:25 a.m.)
Issued	11 years, 6 months ago (Feb. 7, 2014)
Published	11 years, 6 months ago (Feb. 7, 2014)
Published Online	11 years, 6 months ago (Feb. 7, 2014)
Published Print	11 years, 1 month ago (July 10, 2014)

Funders 0

None

BibTeX

@article{Abou_Gharbia_2014, title={Discovery of Innovative Therapeutics: Today’s Realities and Tomorrow’s Vision. 2. Pharma’s Challenges and Their Commitment to Innovation}, volume={57}, ISSN={1520-4804}, url={http://dx.doi.org/10.1021/jm401564r}, DOI={10.1021/jm401564r}, number={13}, journal={Journal of Medicinal Chemistry}, publisher={American Chemical Society (ACS)}, author={Abou-Gharbia, Magid and Childers, Wayne E.}, year={2014}, month=feb, pages={5525–5553} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        6,
        25
      ]
    ],
    "date-time": "2025-06-25T05:25:32Z",
    "timestamp": 1750829132335
  },
  "reference-count": 158,
  "publisher": "American Chemical Society (ACS)",
  "issue": "13",
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2014,
        7,
        10
      ]
    ]
  },
  "DOI": "10.1021/jm401564r",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2014,
        1,
        15
      ]
    ],
    "date-time": "2014-01-15T15:57:29Z",
    "timestamp": 1389801449000
  },
  "page": "5525-5553",
  "source": "Crossref",
  "is-referenced-by-count": 42,
  "title": "Discovery of Innovative Therapeutics: Today\u2019s Realities and Tomorrow\u2019s Vision. 2. Pharma\u2019s Challenges and Their Commitment to Innovation",
  "prefix": "10.1021",
  "volume": "57",
  "author": [
    {
      "given": "Magid",
      "family": "Abou-Gharbia",
      "sequence": "first",
      "affiliation": [
        {
          "name": "Moulder\rCenter for Drug Discovery\rResearch, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, Pennsylvania 19140, United States"
        }
      ]
    },
    {
      "given": "Wayne E.",
      "family": "Childers",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "Moulder\rCenter for Drug Discovery\rResearch, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, Pennsylvania 19140, United States"
        }
      ]
    }
  ],
  "member": "316",
  "published-online": {
    "date-parts": [
      [
        2014,
        2,
        7
      ]
    ]
  },
  "reference": [
    {
      "key": "ref1/cit1",
      "unstructured": "Arlington, S.From Vision to Decision: Pharma 2020. Technical Report from PricewaterhouseCoopers: 2012; http://www.pwc.com/jp/ja/japan-knowledge/archive/assets/pdf/pharma-2020-vision-to-decision.pdf."
    },
    {
      "key": "ref2/cit2",
      "doi-asserted-by": "crossref",
      "first-page": "5659",
      "DOI": "10.1021/jm400330j",
      "volume": "56",
      "author": "Abou-Gharbia M.",
      "year": "2013",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "ref3/cit3",
      "doi-asserted-by": "crossref",
      "first-page": "1239",
      "DOI": "10.1111/j.1476-5381.2010.01127.x",
      "volume": "162",
      "author": "Hughes J.",
      "year": "2011",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "ref4/cit4",
      "doi-asserted-by": "crossref",
      "first-page": "180",
      "DOI": "10.1136/bmj.326.7382.180",
      "volume": "326",
      "author": "Grech E.",
      "year": "2003",
      "journal-title": "Brit. Med. J."
    },
    {
      "key": "ref5/cit5",
      "doi-asserted-by": "crossref",
      "first-page": "545",
      "DOI": "10.1007/s00109-011-0729-3",
      "volume": "89",
      "author": "Li Y.",
      "year": "2011",
      "journal-title": "J. Mol. Med."
    },
    {
      "key": "ref6/cit6",
      "first-page": "914",
      "volume": "4",
      "author": "Harikumar R.",
      "year": "2012",
      "journal-title": "Int. J. PharmTech Res."
    },
    {
      "key": "ref7/cit7",
      "volume-title": "Topics on Drug Metabolism",
      "author": "Alvarez-Lueje A.",
      "year": "2012"
    },
    {
      "key": "ref8/cit8",
      "doi-asserted-by": "crossref",
      "first-page": "4",
      "DOI": "10.1007/s11481-009-9156-4",
      "volume": "5",
      "author": "Nordstrom A.",
      "year": "2010",
      "journal-title": "J. Neuroimmune Pharmacol."
    },
    {
      "key": "ref9/cit9",
      "doi-asserted-by": "crossref",
      "first-page": "1501",
      "DOI": "10.1021/cr0782426",
      "volume": "108",
      "author": "Ametamey S.",
      "year": "2008",
      "journal-title": "Chem. Rev."
    },
    {
      "key": "ref10/cit10",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "DOI": "10.2967/jnumed.112.111476",
      "volume": "54",
      "author": "Bailey D.",
      "year": "2013",
      "journal-title": "J. Nucl. Med."
    },
    {
      "key": "ref11/cit11",
      "doi-asserted-by": "crossref",
      "first-page": "1959",
      "DOI": "10.1007/s00259-010-1390-8",
      "volume": "37",
      "author": "Mariani G.",
      "year": "2010",
      "journal-title": "Eur. J. Nucl. Med. Mol. Imaging"
    },
    {
      "key": "ref12/cit12",
      "unstructured": "Drug Discovery and Development: Understanding the R&D Process; Report from the Pharmaceutical Research and Manufacturers of America:Washington, DC, 2007; http://www.innovation.org/drug_discovery/objects/pdf/RD_Brochure.pdf."
    },
    {
      "key": "ref13/cit13",
      "doi-asserted-by": "crossref",
      "first-page": "993",
      "DOI": "10.1038/nrd2199",
      "volume": "5",
      "author": "Overington J.",
      "year": "2006",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref14/cit14",
      "doi-asserted-by": "crossref",
      "first-page": "727",
      "DOI": "10.1038/nrd892",
      "volume": "1",
      "author": "Hopkins A.",
      "year": "2002",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref15/cit15",
      "doi-asserted-by": "crossref",
      "first-page": "665",
      "DOI": "10.1038/nrd1156",
      "volume": "2",
      "author": "Kubiyni H.",
      "year": "2003",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref16/cit16",
      "doi-asserted-by": "crossref",
      "first-page": "1239",
      "DOI": "10.1111/j.1476-5381.2010.01127.x",
      "volume": "162",
      "author": "Hughes J.",
      "year": "2011",
      "journal-title": "Br. J. Pharmacol."
    },
    {
      "key": "ref17/cit17",
      "doi-asserted-by": "crossref",
      "first-page": "11178",
      "DOI": "10.1073/pnas.1204524109",
      "volume": "109",
      "author": "Gregori-Puigjane E.",
      "year": "2012",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "ref18/cit18",
      "doi-asserted-by": "crossref",
      "first-page": "1394",
      "DOI": "10.1126/science.1169920",
      "volume": "324",
      "author": "Boguski M.",
      "year": "2009",
      "journal-title": "Science"
    },
    {
      "key": "ref19/cit19",
      "doi-asserted-by": "crossref",
      "first-page": "581",
      "DOI": "10.1038/nrd4051",
      "volume": "12",
      "author": "Plenge R. M.",
      "year": "2013",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref20/cit20",
      "first-page": "23",
      "volume": "1",
      "author": "Chen X.-P.",
      "year": "2007",
      "journal-title": "Drug Discovery Ther."
    },
    {
      "key": "ref21/cit21",
      "doi-asserted-by": "crossref",
      "first-page": "194",
      "DOI": "10.1002/cmdc.201100498",
      "volume": "7",
      "author": "Brunschweiger A.",
      "year": "2012",
      "journal-title": "ChemMedChem"
    },
    {
      "key": "ref22/cit22",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "DOI": "10.1021/ci800324m",
      "volume": "49",
      "author": "Halgren T.",
      "year": "2009",
      "journal-title": "J. Chem. Inf. Model."
    },
    {
      "key": "ref23/cit23",
      "doi-asserted-by": "crossref",
      "first-page": "9344",
      "DOI": "10.1073/pnas.1300011110",
      "volume": "110",
      "author": "Skolnick J.",
      "year": "2013",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "ref24/cit24",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1016/j.drudis.2009.09.011",
      "volume": "15",
      "author": "Campbell S.",
      "year": "2010",
      "journal-title": "Drug Discovery Today"
    },
    {
      "key": "ref25/cit25",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "DOI": "10.1016/j.cbpa.2006.06.014",
      "volume": "10",
      "author": "Keller T.",
      "year": "2006",
      "journal-title": "Curr. Opin. Chem. Biol."
    },
    {
      "key": "ref26/cit26",
      "doi-asserted-by": "crossref",
      "first-page": "337",
      "DOI": "10.1016/j.ddtec.2004.11.007",
      "volume": "1",
      "author": "Lipinski C.",
      "year": "2004",
      "journal-title": "Drug Discovery Today"
    },
    {
      "key": "ref27/cit27",
      "first-page": "6",
      "volume-title": "New Synthetic Technologies in Medicinal Chemistry",
      "author": "Merritt A.",
      "year": "2012"
    },
    {
      "key": "ref28/cit28",
      "volume-title": "Drug-Like Properties: Concepts, Structure Design and Methods",
      "author": "Kerns E.",
      "year": "2008"
    },
    {
      "key": "ref29/cit29",
      "doi-asserted-by": "crossref",
      "first-page": "358",
      "DOI": "10.2174/156802611794480927",
      "volume": "11",
      "author": "Gleeson M.",
      "year": "2011",
      "journal-title": "Curr. Top. Med. Chem."
    },
    {
      "key": "ref30/cit30",
      "doi-asserted-by": "crossref",
      "first-page": "711",
      "DOI": "10.1038/nrd1470",
      "volume": "3",
      "author": "Kola I.",
      "year": "2004",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref31/cit31",
      "volume": "21",
      "author": "Gilbert J.",
      "year": "2003",
      "journal-title": "In Vivo Bus. Med. Rep."
    },
    {
      "key": "ref32/cit32",
      "first-page": "562",
      "volume": "75",
      "author": "Kleemann A.",
      "year": "2013",
      "journal-title": "Pharm. Ind."
    },
    {
      "key": "ref33/cit33",
      "unstructured": "Stone, K.Big pharma\u2019s merger mania.About.com;http://pharma.about.com/od/BigPharma/tp/Big-Pharmas-Merger-Mania.htm."
    },
    {
      "key": "ref34/cit34",
      "unstructured": "Deal Search Online Home Page, Irving Levin Associates, Inc.http://www.levinassociates.com/dealsearch/."
    },
    {
      "key": "ref35/cit35",
      "doi-asserted-by": "crossref",
      "first-page": "559",
      "DOI": "10.1038/nrd3514",
      "volume": "10",
      "author": "Lamattina J.",
      "year": "2011",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref36/cit36",
      "doi-asserted-by": "crossref",
      "first-page": "963",
      "DOI": "10.1038/nrd2961-c1",
      "volume": "10",
      "author": "Firestone R.",
      "year": "2011",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref37/cit37",
      "doi-asserted-by": "crossref",
      "first-page": "959",
      "DOI": "10.1038/nrd2961",
      "volume": "8",
      "author": "Munos B.",
      "year": "2009",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref38/cit38",
      "doi-asserted-by": "crossref",
      "unstructured": "Comanor, W.; Scherer, F.Mergers and innovation in the pharmaceutical industry. Harvard Kennedy School Faculty Research Working Paper Series, 2011; https://research.hks.harvard.edu/publications/workingpapers/citation.aspx?PubId=8053&type=FN&PersonId=219.",
      "DOI": "10.2139/ssrn.2190201"
    },
    {
      "key": "ref39/cit39",
      "unstructured": "Amgen Press Release, Aug 25, 2013;http://www.amgen.com/media/media_pr_detail.jsp?releaseID=1849611."
    },
    {
      "key": "ref40/cit40",
      "doi-asserted-by": "crossref",
      "first-page": "191",
      "DOI": "10.1038/nrd3681",
      "volume": "11",
      "author": "Scannell J.",
      "year": "2012",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref41/cit41",
      "doi-asserted-by": "crossref",
      "first-page": "552",
      "DOI": "10.1093/oxfordhb/9780199742998.013.0018",
      "volume-title": "The Oxford Handbook of The Economics of the Biopharmaceutical Industry",
      "author": "Grabowski H.",
      "year": "2012"
    },
    {
      "key": "ref42/cit42",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1057/9781137005908",
      "volume-title": "Mega Mergers and Acquisitions: Case Studies from Key Industries",
      "author": "Kumar B.",
      "year": "2012"
    },
    {
      "key": "ref43/cit43",
      "doi-asserted-by": "crossref",
      "unstructured": "Tjandrawinata, R.; Simanjuntak, D.The impact of mergers and acquisitions in research-based pharmaceutical companies on productivity.Social Science Research Network:Rochester, NY, 2012; http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1981889.",
      "DOI": "10.2139/ssrn.1981889"
    },
    {
      "key": "ref44/cit44",
      "unstructured": "LaMattina, J.A holiday gift from Merck\u2019s Ken Frazier.Drug Truths, Dec 20, 2011; http://johnlamattina.wordpress.com/2011/12/20/a-holiday-gift-from-mercks-ken-frazier/."
    },
    {
      "key": "ref45/cit45",
      "unstructured": "Weaver, C.Merck CEO defends strategy to pursue new drugs, research.Wall Street Journal, Dec 13, 2011; http://online.wsj.com/article/BT-CO-20111213-711338.html."
    },
    {
      "key": "ref46/cit46",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "DOI": "10.1002/mde.1343",
      "volume": "28",
      "author": "Danzon P.",
      "year": "2007",
      "journal-title": "Managerial and Decision Economics"
    },
    {
      "key": "ref47/cit47",
      "first-page": "262",
      "volume-title": "Economics of Corporate Governance and Mergers",
      "author": "Grabowski H.",
      "year": "2008"
    },
    {
      "key": "ref48/cit48",
      "unstructured": "Davis, P. J.Beyond the patent cliff \u2013 signs of recovery in biopharma\u2019s new normal.Accenture Life Sciences, 2012; http://www.accenture.com/SiteCollectionDocuments/PDF/Accenture-Life-Sciences-Beyond-The-Patent-Cliff-Signs-Of-Recovery-in-Biopharmas-New-Normal.pdf."
    },
    {
      "key": "ref49/cit49",
      "unstructured": "World preview 2018: Embracing the patent cliff.EvaluatePharma, 2012; http://info.evaluatepharma.com/WP2018_ELS_LP.html."
    },
    {
      "key": "ref50/cit50",
      "unstructured": "Lipitor sales data.Drugs.com;http://www.drugs.com/stats/lipitor."
    },
    {
      "key": "ref51/cit51",
      "doi-asserted-by": "crossref",
      "first-page": "370",
      "DOI": "10.1126/science.1176116",
      "volume": "326",
      "author": "Higgins M.",
      "year": "2009",
      "journal-title": "Science"
    },
    {
      "key": "ref52/cit52",
      "unstructured": "Paragraph four explained: Why generic drug companies challenge patents.Parry Ashfold, Inc.:Exton, PA, 2012; http://paragraphfour.com/explained/why_challenge.html."
    },
    {
      "key": "ref53/cit53",
      "doi-asserted-by": "crossref",
      "first-page": "12",
      "DOI": "10.1038/nrd3356",
      "volume": "10",
      "author": "Harrison C.",
      "year": "2011",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref54/cit54",
      "unstructured": "Powers, M.Despite short-term revenue hit, Sanofi manages patent cliff.BioWorld;http://www.bioworld.com/content/despite-short-term-revenue-hit-sanofi-manages-patent-cliff-0."
    },
    {
      "key": "ref55/cit55",
      "doi-asserted-by": "crossref",
      "first-page": "e7941",
      "DOI": "10.1136/bmj.e7941",
      "volume": "345",
      "author": "Hitchings A.",
      "year": "2012",
      "journal-title": "Br. Med. J."
    },
    {
      "key": "ref56/cit56",
      "unstructured": "Buente, M.; Danner, S.; Weissbacker, S.; Ramme, C.Pharma emerging markets 2.0. How emerging markets are driving the transformation of the pharmaceutical industry.Booz & Co, 2013; http://www.booz.com/media/file/BoozCo_Pharma-Emerging-Markets-2.0.pdf."
    },
    {
      "key": "ref57/cit57",
      "unstructured": "Schumacher, C.CRAMS outsourcing in pharmaceutical and chemical research and manufacturing, part II.StepChange Innovations GmbH, 2012; http://blog.stepchange-innovations.com/2012/08/crams-outsourcing-in-pharmaceutical-and-chemical-research-and-manufacturing-part-ii/#_edn1."
    },
    {
      "key": "ref58/cit58",
      "first-page": "54",
      "volume": "14",
      "author": "Getz K.",
      "year": "2012",
      "journal-title": "Contract Pharma"
    },
    {
      "key": "ref59/cit59",
      "doi-asserted-by": "crossref",
      "first-page": "431",
      "DOI": "10.1016/j.respol.2006.01.006",
      "volume": "35",
      "author": "Roijakkers N.",
      "year": "2006",
      "journal-title": "Res. Policy"
    },
    {
      "key": "ref60/cit60",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "DOI": "10.1016/j.hitech.2004.03.003",
      "volume": "15",
      "author": "McCutchen W. W.",
      "year": "2004",
      "journal-title": "J. High Technol. Manage. Res."
    },
    {
      "key": "ref61/cit61",
      "unstructured": "The use of medicines in the United States: Review of 2011.IMS Institute for Healthcare Informatics, April 2012; http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_Report_2011.pdf."
    },
    {
      "key": "ref62/cit62",
      "unstructured": "Barry, C.; Arad, R.; Johnston, A.; Parent, A.; Ansell, L.; Arnold, M. (2012) patent litigation study.PricewaterhouseCoopers, Sept 2012;http://www.pwc.com/us/en/forensic-services/publications/2012-patent-litigation-study.jhtml."
    },
    {
      "key": "ref63/cit63",
      "doi-asserted-by": "crossref",
      "first-page": "491",
      "DOI": "10.1056/NEJMp1206573",
      "volume": "376",
      "author": "Rai A.",
      "year": "2012",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "ref64/cit64",
      "unstructured": "Agreements filed with the Federal Trade Commission under the Medicare Prescription Drug, Improvement and Moderinization Act of 2003: Overview of agreements filed filed in FY 2012; A report by the Bureau of Competition, Federal Trade Commission:Washington, DC, Jan 2013; http://www.ftc.gov/os/2013/01/130117mmareport.pdf."
    },
    {
      "key": "ref65/cit65",
      "unstructured": "List of authorized generic drugs.U.S. Food and Drug Administration:Washington , DC;http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ucm126389.htm."
    },
    {
      "key": "ref66/cit66",
      "unstructured": "More than eight in ten Americans want the option of choosing authorized generic prescription drugs.Roper Public Affairs & Media, 2005; http://www.prasco.com/wp-content/uploads/2012/03/Roper_Poll.pdf."
    },
    {
      "key": "ref67/cit67",
      "unstructured": "Authorized generic drugs: Short-term effects and long-term impact.Federal Trade Commission:Washington, DC, 2011."
    },
    {
      "key": "ref69/cit69",
      "doi-asserted-by": "crossref",
      "first-page": "900",
      "DOI": "10.1007/s12257-012-0095-1",
      "volume": "17",
      "author": "Ryu J. K.",
      "year": "2012",
      "journal-title": "Biotechnol. Bioprocess Eng."
    },
    {
      "key": "ref70/cit70",
      "unstructured": "Global biopharmaceutical market expected to reach $320 billion by 2020.Global Information, Inc., Oct 4, 2012; http://www.giiresearch.com/press/6805.shtml."
    },
    {
      "key": "ref71/cit71",
      "doi-asserted-by": "crossref",
      "first-page": "7",
      "DOI": "10.1016/S0140-6736(12)60771-5",
      "volume": "380",
      "author": "Stein E. A.",
      "year": "2012",
      "journal-title": "Lancet"
    },
    {
      "key": "ref72/cit72",
      "doi-asserted-by": "crossref",
      "first-page": "2497",
      "DOI": "10.1001/jama.2012.25790",
      "volume": "308",
      "author": "Sullivan D.",
      "year": "2012",
      "journal-title": "JAMA"
    },
    {
      "key": "ref73/cit73",
      "unstructured": "Herd, T.; Sheehy, D. A.; Ural, A.Mergers & acquisitions: A strategy for focused growth in the biopharmaceutical industry during uncertain times.Accenture, 2011; http://www.accenture.com/SiteCollectionDocuments/PDF/Accenture_A_Strategy_for_Focused_Growth.pdf."
    },
    {
      "key": "ref74/cit74",
      "first-page": "2132",
      "volume": "4",
      "author": "Kanase S. J.",
      "year": "2013",
      "journal-title": "Int. J. Pharm. Sci Res."
    },
    {
      "key": "ref75/cit75",
      "doi-asserted-by": "crossref",
      "first-page": "112",
      "DOI": "10.1186/ar3310",
      "volume": "13",
      "author": "Kay J.",
      "year": "2011",
      "journal-title": "Arthritis Res Ther."
    },
    {
      "key": "ref76/cit76",
      "unstructured": "Patient Protection and Affordable Care Act of 2009, Pub. L. No. 111-148, Title VII, Subtitle A Biologics Price Competition and Innovation Act of 2009, \u00a77001-7003;http://www.gpo.gov/fdsys/pkg/BILLS-111hr3590enr/pdf/BILLS-111hr3590enr.pdf."
    },
    {
      "key": "ref77/cit77",
      "first-page": "451",
      "volume-title": "Annual Reports in Medicinal Chemistry",
      "author": "Notte G. T.",
      "year": "2013"
    },
    {
      "key": "ref78/cit78",
      "first-page": "15",
      "author": "Jarvis L. M.",
      "year": "2013",
      "journal-title": "Chem. Eng. News"
    },
    {
      "key": "ref79/cit79",
      "unstructured": "LaMattina, J.When it comes to NDA approvals, is 30 the new 50?Drug Truths, 2012; http://johnlamattina.wordpress.com/2012/01/17/when-it-comes-to-nda-approvals-is-30-the-new-50/."
    },
    {
      "key": "ref80/cit80",
      "unstructured": "Armstrong, W.FDA\u2019s approvable problem.Pharmaceutical Executive, Nov 1, 2007; http://www.pharmexec.com/pharmexec/PE+Features/FDAs-Approvable-Problem/ArticleStandard/Article/detail/469652."
    },
    {
      "key": "ref81/cit81",
      "unstructured": "FDA revised process for responding to drug applications; Press Release by the U.S. Food and Drug Administration, July 8, 2008; http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116920.htm. Completehttp://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2004-N-0510-nfr.pdf."
    },
    {
      "key": "ref82/cit82",
      "doi-asserted-by": "crossref",
      "first-page": "e4348",
      "DOI": "10.1136/bmj.e4348",
      "volume": "344",
      "author": "Light D.",
      "year": "2012",
      "journal-title": "Br. Med. J."
    },
    {
      "key": "ref83/cit83",
      "unstructured": "FDA\u2019s consideration of evidence from certain clinical trials.United States Government Accountability Office, July 2010; http://www.gao.gov/assets/310/308301.pdf."
    },
    {
      "key": "ref84/cit84",
      "doi-asserted-by": "crossref",
      "first-page": "307",
      "DOI": "10.1057/jcb.2008.6",
      "volume": "14",
      "author": "Bode-Greuel K.",
      "year": "2008",
      "journal-title": "J. Commer. Biotechnol."
    },
    {
      "key": "ref85/cit85",
      "doi-asserted-by": "crossref",
      "first-page": "105",
      "DOI": "10.1038/clpt.2009.71",
      "volume": "86",
      "author": "Poland B.",
      "year": "2009",
      "journal-title": "Clin. Pharmacol. Ther."
    },
    {
      "key": "ref86/cit86",
      "unstructured": "Sartori, V.; Steinmann, M.; Evers, M.; Jantzer, P.Value-driven drug development \u2013 unlocking the value of your pipeline.McKinsey Quarterly, 2011; http://www.mckinsey.com/Search.aspx?q=sartori&l=Insights%20%26%20Publications."
    },
    {
      "key": "ref87/cit87",
      "unstructured": "Dykstra, K.; Hodge, L.; Poland, B.; Carrothers, T. J.Methods for developing differentiated drug products.Pharsight, 2009; http://www.pharsight.com/library/Methods%20for%20Developing%20Differentiated%20Drug%20Products.pdf."
    },
    {
      "key": "ref88/cit88",
      "doi-asserted-by": "crossref",
      "first-page": "409",
      "DOI": "10.1038/nrd3462",
      "volume": "10",
      "author": "Frye S.",
      "year": "2011",
      "journal-title": "Nature Rev. Drug Discovery"
    },
    {
      "key": "ref89/cit89",
      "doi-asserted-by": "crossref",
      "first-page": "313",
      "DOI": "10.1021/ml400012g",
      "volume": "4",
      "author": "Huryn D. H.",
      "year": "2013",
      "journal-title": "ACS Med. Chem. Lett."
    },
    {
      "key": "ref90/cit90",
      "doi-asserted-by": "crossref",
      "first-page": "713",
      "DOI": "10.1038/nrd3439-c1",
      "volume": "10",
      "author": "Prinz F.",
      "year": "2011",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref91/cit91",
      "doi-asserted-by": "crossref",
      "first-page": "30cm16-1",
      "DOI": "10.1126/scitranslmed.3000169",
      "volume": "2",
      "author": "Silber B. M.",
      "year": "2010",
      "journal-title": "Sci. Transl. Med."
    },
    {
      "key": "ref92/cit92",
      "doi-asserted-by": "crossref",
      "first-page": "7161",
      "DOI": "10.1021/jm400132d",
      "volume": "56",
      "author": "Huryn D. H.",
      "year": "2013",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "ref93/cit93",
      "first-page": "1",
      "volume": "4",
      "author": "Kotz J.",
      "year": "2011",
      "journal-title": "SciBX"
    },
    {
      "key": "ref94/cit94",
      "first-page": "314",
      "volume": "20",
      "author": "Donatella V.",
      "year": "2010",
      "journal-title": "Biochemica Medica"
    },
    {
      "key": "ref95/cit95",
      "doi-asserted-by": "crossref",
      "first-page": "711",
      "DOI": "10.1038/nrd1470",
      "volume": "3",
      "author": "Kola I.",
      "year": "2004",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref96/cit96",
      "doi-asserted-by": "crossref",
      "first-page": "387",
      "DOI": "10.1111/j.1365-2125.1988.tb03318.x",
      "volume": "25",
      "author": "Prentis R. A.",
      "year": "1988",
      "journal-title": "Br. J. Clin. Pharmacol."
    },
    {
      "key": "ref98/cit98",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1016/S0169-409X(96)00423-1",
      "volume": "23",
      "author": "Lapinski P. A.",
      "year": "1997",
      "journal-title": "Adv. Drug Delivery Res."
    },
    {
      "key": "ref99/cit99",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "DOI": "10.1038/nrd3367",
      "volume": "10",
      "author": "Gleeson M. P.",
      "year": "2011",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref100/cit100",
      "doi-asserted-by": "crossref",
      "first-page": "5980",
      "DOI": "10.1016/j.bmcl.2013.08.029",
      "volume": "23",
      "author": "Shultz M. D.",
      "year": "2013",
      "journal-title": "Bioorg. Med. Chem. Lett."
    },
    {
      "key": "ref101/cit101",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1007/s10822-012-9631-5",
      "volume": "27",
      "author": "Kenny P. W.",
      "year": "2013",
      "journal-title": "J. Comput.-Aided Mol. Des."
    },
    {
      "key": "ref102/cit102",
      "doi-asserted-by": "crossref",
      "first-page": "805",
      "DOI": "10.1021/jm049661n",
      "volume": "48",
      "author": "Refsgaard H. H. F.",
      "year": "2005",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "ref103/cit103",
      "doi-asserted-by": "crossref",
      "first-page": "1907",
      "DOI": "10.4155/fmc.12.150",
      "volume": "4",
      "author": "Peach M. L.",
      "year": "2012",
      "journal-title": "Future Med. Chem."
    },
    {
      "key": "ref104/cit104",
      "doi-asserted-by": "crossref",
      "first-page": "492",
      "DOI": "10.1021/ci2003544",
      "volume": "52",
      "author": "AbdulHameed M. D.",
      "year": "2012",
      "journal-title": "J. Chem. Inf. Model."
    },
    {
      "key": "ref105/cit105",
      "doi-asserted-by": "crossref",
      "first-page": "356",
      "DOI": "10.1016/j.taap.2009.08.022",
      "volume": "241",
      "author": "Valerio L. G.",
      "year": "2009",
      "journal-title": "Toxicol. Appl. Pharmacol."
    },
    {
      "key": "ref106/cit106",
      "doi-asserted-by": "crossref",
      "first-page": "2572",
      "DOI": "10.1021/ci900286s",
      "volume": "49",
      "author": "Hewitt M.",
      "year": "2009",
      "journal-title": "J Chem. Inf. Model."
    },
    {
      "key": "ref107/cit107",
      "first-page": "53",
      "volume-title": "Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability",
      "volume": "40",
      "author": "Davis A. M.",
      "year": "2009",
      "edition": "2"
    },
    {
      "key": "ref108/cit108",
      "doi-asserted-by": "crossref",
      "first-page": "464",
      "DOI": "10.1016/S1359-6446(05)03386-6",
      "volume": "10",
      "author": "Abad-Zapatero C.",
      "year": "2005",
      "journal-title": "Drug Discovery Today"
    },
    {
      "key": "ref109/cit109",
      "doi-asserted-by": "crossref",
      "first-page": "430",
      "DOI": "10.1016/S1359-6446(04)03069-7",
      "volume": "9",
      "author": "Hopkins A. L.",
      "year": "2004",
      "journal-title": "Drug Discovery Today"
    },
    {
      "key": "ref110/cit110",
      "volume-title": "Ligand Efficiency Indices for Drug Discovery: Towards an Atlas-Guided Paradigm",
      "author": "Abad-Zapatero C.",
      "year": "2013"
    },
    {
      "key": "ref111/cit111",
      "doi-asserted-by": "crossref",
      "first-page": "749",
      "DOI": "10.1038/nrd3552",
      "volume": "10",
      "author": "Leeson P. D.",
      "year": "2011",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref112/cit112",
      "doi-asserted-by": "crossref",
      "first-page": "2986",
      "DOI": "10.1021/jm100118x",
      "volume": "53",
      "author": "Perola E.",
      "year": "2010",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "ref113/cit113",
      "doi-asserted-by": "crossref",
      "first-page": "1308",
      "DOI": "10.1021/ci010366a",
      "volume": "41",
      "author": "Oprea T. I.",
      "year": "2001",
      "journal-title": "J. Chem. Inf. Comput. Sci."
    },
    {
      "key": "ref114/cit114",
      "first-page": "1",
      "volume": "2",
      "author": "Shahzad A.",
      "year": "2011",
      "journal-title": "Transl. Biomed."
    },
    {
      "key": "ref115/cit115",
      "unstructured": "NIH Bench-to-Bedside Program Home Page.http://clinicalcenter.nih.gov/ccc/btb/."
    },
    {
      "key": "ref116/cit116",
      "doi-asserted-by": "crossref",
      "first-page": "566",
      "DOI": "10.1038/nrd1130",
      "volume": "2",
      "author": "Frank R.",
      "year": "2003",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref117/cit117",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "DOI": "10.1067/mcp.2001.113989",
      "volume": "69",
      "author": "Biomarkers Definitions Working Group",
      "year": "2001",
      "journal-title": "Clin. Pharmacol. Ther."
    },
    {
      "key": "ref118/cit118",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "DOI": "10.1097/COH.0b013e32833ed177",
      "volume": "5",
      "author": "Strimbu K.",
      "year": "2010",
      "journal-title": "Curr. Opin. HIV AIDS"
    },
    {
      "key": "ref119/cit119",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1007/978-1-4419-1132-2_1",
      "volume-title": "Pharmaceutical Biotechnology: Advances in Experimental Biology and Medicine",
      "volume": "655",
      "author": "Day M.",
      "year": "2009"
    },
    {
      "key": "ref120/cit120",
      "doi-asserted-by": "crossref",
      "first-page": "310",
      "DOI": "10.1016/j.tips.2006.04.004",
      "volume": "27",
      "author": "Lee C.-M.",
      "year": "2006",
      "journal-title": "Trends Pharmacol. Sci."
    },
    {
      "key": "ref121/cit121",
      "doi-asserted-by": "crossref",
      "first-page": "286",
      "DOI": "10.1176/ajp.156.2.286",
      "volume": "156",
      "author": "Kapur S.",
      "year": "1999",
      "journal-title": "Am. J. Psychiatry"
    },
    {
      "key": "ref122/cit122",
      "doi-asserted-by": "crossref",
      "first-page": "2290",
      "DOI": "10.1002/cncr.11320",
      "volume": "97",
      "author": "Chawla S. P.",
      "year": "2003",
      "journal-title": "Cancer"
    },
    {
      "key": "ref123/cit123",
      "doi-asserted-by": "crossref",
      "first-page": "216",
      "DOI": "10.1016/j.biopsych.2005.07.013",
      "volume": "59",
      "author": "Keller M.",
      "year": "2006",
      "journal-title": "Biol. Psychiatry"
    },
    {
      "key": "ref124/cit124",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "DOI": "10.1016/S0531-5565(02)00267-X",
      "volume": "38",
      "author": "Schirmer M.",
      "year": "2003",
      "journal-title": "Exp. Gerentol."
    },
    {
      "key": "ref125/cit125",
      "doi-asserted-by": "crossref",
      "first-page": "41",
      "DOI": "10.1016/S0169-409X(99)00055-1",
      "volume": "41",
      "author": "Bhatnager A.",
      "year": "2000",
      "journal-title": "Adv. Drug Delivery Rev."
    },
    {
      "key": "ref126/cit126",
      "doi-asserted-by": "crossref",
      "first-page": "293",
      "DOI": "10.1016/S1359-6446(01)01684-1",
      "volume": "6",
      "author": "Aboagye E. O.",
      "year": "2001",
      "journal-title": "Drug Discovery Today"
    },
    {
      "key": "ref127/cit127",
      "first-page": "S19",
      "volume": "6",
      "author": "Taneja S. S.",
      "year": "2004",
      "journal-title": "Rev. Urol."
    },
    {
      "key": "ref128/cit128",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "DOI": "10.2214/ajr.183.2.1830519",
      "volume": "183",
      "author": "Schettino C. J.",
      "year": "2004",
      "journal-title": "Am. J. Roentgenol."
    },
    {
      "key": "ref129/cit129",
      "doi-asserted-by": "crossref",
      "first-page": "401",
      "DOI": "10.1208/s12248-008-9041-8",
      "volume": "10",
      "author": "Krishna R.",
      "year": "2008",
      "journal-title": "AAPS J"
    },
    {
      "key": "ref130/cit130",
      "doi-asserted-by": "crossref",
      "first-page": "11034",
      "DOI": "10.3390/ijms140611034",
      "volume": "14",
      "author": "Velonas V. M.",
      "year": "2013",
      "journal-title": "Int. J. Mol. Sci."
    },
    {
      "key": "ref131/cit131",
      "unstructured": "Guidance for Industry: S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. U.S. Food and Drug Administration, Oct 2005; http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm074963.pdf."
    },
    {
      "key": "ref132/cit132",
      "doi-asserted-by": "crossref",
      "first-page": "560",
      "DOI": "10.1038/nrd3115",
      "volume": "9",
      "author": "Hampel H.",
      "year": "2010",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref133/cit133",
      "doi-asserted-by": "crossref",
      "first-page": "20-1",
      "DOI": "10.1186/1750-1326-8-20",
      "volume": "8",
      "author": "Rosen C.",
      "year": "2013",
      "journal-title": "Mol. Neurodegener."
    },
    {
      "key": "ref134/cit134",
      "doi-asserted-by": "crossref",
      "first-page": "1392",
      "DOI": "10.1002/mds.25157",
      "volume": "27",
      "author": "Ravine B.",
      "year": "2012",
      "journal-title": "Mov. Disord."
    },
    {
      "key": "ref135/cit135",
      "doi-asserted-by": "crossref",
      "first-page": "713",
      "DOI": "10.1093/brain/awq008",
      "volume": "133",
      "author": "Hong Z.",
      "year": "2010",
      "journal-title": "Brain"
    },
    {
      "key": "ref136/cit136",
      "first-page": "2825",
      "volume": "58",
      "author": "Baselga J.",
      "year": "1998",
      "journal-title": "Cancer Res."
    },
    {
      "key": "ref137/cit137",
      "doi-asserted-by": "crossref",
      "first-page": "363",
      "DOI": "10.1038/nrd3181",
      "volume": "9",
      "author": "Schilsky R. L.",
      "year": "2010",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref138/cit138",
      "doi-asserted-by": "crossref",
      "first-page": "895",
      "DOI": "10.1038/nrd3603",
      "volume": "10",
      "author": "Chiang A.",
      "year": "2011",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref139/cit139",
      "first-page": "321",
      "volume": "17",
      "author": "Sadigh-Eteghad S.",
      "year": "2012",
      "journal-title": "Neuroscience"
    },
    {
      "key": "ref140/cit140",
      "doi-asserted-by": "crossref",
      "first-page": "40",
      "DOI": "10.1038/sj.mp.4001558",
      "volume": "10",
      "author": "Harrison P.",
      "year": "2005",
      "journal-title": "Mol. Psychiatry"
    },
    {
      "key": "ref141/cit141",
      "doi-asserted-by": "crossref",
      "first-page": "507",
      "DOI": "10.1002/9783527630035.ch21",
      "volume-title": "Analogue-Based Drug Discovery II",
      "author": "Abou-Gharbia M. A.",
      "year": "2010"
    },
    {
      "key": "ref142/cit142",
      "doi-asserted-by": "crossref",
      "first-page": "5",
      "DOI": "10.4088/JCP.v64n0301",
      "volume": "64",
      "author": "Nelson J. C.",
      "year": "2003",
      "journal-title": "J. Clin. Psychiatry"
    },
    {
      "key": "ref143/cit143",
      "doi-asserted-by": "crossref",
      "first-page": "657",
      "DOI": "10.1124/jpet.106.103382",
      "volume": "318",
      "author": "Deecher D. C.",
      "year": "2006",
      "journal-title": "J. Pharmacol. Exp. Ther."
    },
    {
      "key": "ref144/cit144",
      "doi-asserted-by": "crossref",
      "first-page": "2899",
      "DOI": "10.1021/jm00172a035",
      "volume": "33",
      "author": "Yardley J. P.",
      "year": "1990",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "ref145/cit145",
      "doi-asserted-by": "crossref",
      "first-page": "39",
      "DOI": "10.1097/JCP.0b013e318192e4c1",
      "volume": "29",
      "author": "Preskorn S.",
      "year": "2009",
      "journal-title": "J. Clin. Psychopharmacol."
    },
    {
      "key": "ref146/cit146",
      "doi-asserted-by": "crossref",
      "first-page": "2",
      "DOI": "10.1021/jm8012823",
      "volume": "52",
      "author": "Abou-Gharbia M.",
      "year": "2009",
      "journal-title": "J. Med. Chem."
    },
    {
      "key": "ref147/cit147",
      "doi-asserted-by": "crossref",
      "first-page": "1543",
      "DOI": "10.1351/PAC-CON-11-11-09",
      "volume": "84",
      "author": "Abou-Gharbia M.",
      "year": "2012",
      "journal-title": "Pure Appl. Chem."
    },
    {
      "key": "ref148/cit148",
      "first-page": "316",
      "volume-title": "Accounts in Drug Discovery",
      "author": "Graziani E. I.",
      "year": "2011"
    },
    {
      "key": "ref149/cit149",
      "doi-asserted-by": "crossref",
      "first-page": "3",
      "DOI": "10.1046/j.1523-1755.2001.00460.x",
      "volume": "59",
      "author": "Saunders R. N.",
      "year": "2001",
      "journal-title": "Kidney Int."
    },
    {
      "key": "ref150/cit150",
      "doi-asserted-by": "crossref",
      "first-page": "671",
      "DOI": "10.1038/nrd2062",
      "volume": "5",
      "author": "Faiver S.",
      "year": "2006",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref151/cit151",
      "first-page": "3749S",
      "volume": "7",
      "author": "Skotnicki J. S.",
      "year": "2001",
      "journal-title": "Clin. Cancer Res."
    },
    {
      "key": "ref152/cit152",
      "doi-asserted-by": "crossref",
      "first-page": "599",
      "DOI": "10.1038/nrd2382",
      "volume": "6",
      "author": "Rini B.",
      "year": "2007",
      "journal-title": "Nat. Rev. Drug Discovery"
    },
    {
      "key": "ref153/cit153",
      "doi-asserted-by": "crossref",
      "first-page": "239",
      "DOI": "10.1126/science.273.5272.239",
      "volume": "273",
      "author": "Choi J.",
      "year": "1996",
      "journal-title": "Science"
    },
    {
      "key": "ref154/cit154",
      "doi-asserted-by": "crossref",
      "first-page": "184",
      "DOI": "10.1038/ja.2006.26",
      "volume": "59",
      "author": "Summers M. Y.",
      "year": "2006",
      "journal-title": "J. Antibiot."
    },
    {
      "key": "ref155/cit155",
      "doi-asserted-by": "crossref",
      "first-page": "33",
      "DOI": "10.1073/pnas.0710424105",
      "volume": "105",
      "author": "Ruan B.",
      "year": "2008",
      "journal-title": "Proc. Natl. Acad. Sci. U.S.A."
    },
    {
      "key": "ref156/cit156",
      "doi-asserted-by": "crossref",
      "first-page": "977",
      "DOI": "10.1586/erv.09.68",
      "volume": "8",
      "author": "Dinleyici E. C.",
      "year": "2009",
      "journal-title": "Expert Rev. Vaccines"
    },
    {
      "key": "ref157/cit157",
      "doi-asserted-by": "crossref",
      "first-page": "1516",
      "DOI": "10.1345/aph.1Q347",
      "volume": "45",
      "author": "Sucher A. J.",
      "year": "2011",
      "journal-title": "Ann. Pharmacother."
    },
    {
      "key": "ref158/cit158",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "DOI": "10.1111/j.1749-6632.2012.06673.x",
      "volume": "1263",
      "author": "Gruber W. C.",
      "year": "2012",
      "journal-title": "Ann. N.Y. Acad. Sci."
    },
    {
      "key": "ref159/cit159",
      "unstructured": "Brant, A.20 top selling vaccines \u2013 H1, 2012.FierceVaccines, Sept 25, 2012; http://www.fiercevaccines.com/special-report/20-top-selling-vaccines/2012-09-25."
    },
    {
      "key": "ref160/cit160",
      "first-page": "12",
      "volume": "91",
      "author": "Mullin R.",
      "year": "2013",
      "journal-title": "Chem. Eng. News"
    }
  ],
  "container-title": "Journal of Medicinal Chemistry",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://pubs.acs.org/doi/pdf/10.1021/jm401564r",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        6
      ]
    ],
    "date-time": "2023-04-06T00:53:28Z",
    "timestamp": 1680742408000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://pubs.acs.org/doi/10.1021/jm401564r"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2014,
        2,
        7
      ]
    ]
  },
  "references-count": 158,
  "journal-issue": {
    "issue": "13",
    "published-print": {
      "date-parts": [
        [
          2014,
          7,
          10
        ]
      ]
    }
  },
  "alternative-id": [
    "10.1021/jm401564r"
  ],
  "URL": "http://dx.doi.org/10.1021/jm401564r",
  "relation": {},
  "ISSN": [
    "0022-2623",
    "1520-4804"
  ],
  "subject": [],
  "container-title-short": "J. Med. Chem.",
  "published": {
    "date-parts": [
      [
        2014,
        2,
        7
      ]
    ]
  }
}